PharmaCielo Ltd. (TSXV: PCLO)
Canada
· Delayed Price · Currency is CAD
0.0850
-0.0050 (-5.56%)
Dec 3, 2024, 11:09 AM EST
PharmaCielo Company Description
PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada.
Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software.
The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies.
The company has strategic partnership with Benuvia Operations, LLC to produce cGMP pharmaceutical-grade CBD active pharmaceutical ingredients.
PharmaCielo Ltd. is headquartered in Toronto, Canada.
PharmaCielo Ltd.
Country | Canada |
Industry | Drug Manufacturers - Specialty & Generic |
Sector | Healthcare |
CEO | Marc Lustig |
Contact Details
Address: 82 Richmond Street East Toronto, British Columbia M5C 1P1 Canada | |
Website | pharmacielo.com |
Stock Details
Ticker Symbol | PCLO |
Exchange | TSX Venture Exchange |
Fiscal Year | January - December |
Reporting Currency | CAD |
ISIN Number | CA71716K1012 |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Marc Lustig M.B.A., M.Sc. | Chairman and Chief Executive Officer |
Ian D. Atacan B.Sc., C.M.A., C.P.A., M.B.A. | Chief Financial Officer, Corporate Secretary and Director |
Andres Felipe Botero | Chief Operating Officer |
Dr. Decio Rabelo de Castro Filho | Chief Medical Officer |